Table 1.
Respondents’ characteristics
| Type of medical setting (n = 93) | |
|---|---|
| University hospital | 82 (88.2%) |
| Other hospital | 10 (10.8%) |
| Out-patient setting | 1 (1.1%) |
| Geographical location (n = 90) | |
| Americas | 60 (64.5%) |
| Europe | 24 (25.8%) |
| Asia | 4 (4.3%) |
| Africa | 1 (1.1%) |
| Australia | 1 (1.1%) |
| Experience in the field of pediatric rheumatology (n = 92) | |
| < 5 years | 12 (13.0%) |
| 5–10 years | 31 (33.3%) |
| > 10 years | 49 (52.7%) |
| Experience with treatment of patients with COVID-19 (n = 92) | |
| Yes | 58 (63.0%) |
| 1–5 patients | 33 (35.5%) |
| > 5 patients | 25 (26.9%) |
| Pediatric patients | 47 (50.5%) |
| Adult patients | 2 (2.2%) |
| All age categories | 8 (8.7%) |
| No | 34 (36.6%) |